Skip to main content
OpenTrials
Completed

NCT Number: NCT00620880

IVN-CAT-001A Performance of CAST With Different Allergens in Patients With Cat Dander Allergy

Primary objective of the trial:

To determine at which concentration the fusion protein MAT Fel d1 degranulates basophils of cat dander allergic patients, in comparison to a cat dander extract and to Fel d1 alone

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Allergy to Cats

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Zurich, Switzerland

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

1. Patient with Cat Dander Allergy evidenced by positive history 2. Age: 18 to 75 years

Exclusion criteria

1. Use of oral corticosteroids, Chromoglycin, Ketotifen, or any immunosuppressive drugs within the last 2 months 2. Psychiatric disorder resulting in malcompliance 3. Neg. IgE to Cat dander

Treatment and study plan

Blood sample

Behavioral

Sponsors and collaborators

Lead sponsor

University of Zurich

Other

Collaborators

  • ImVision AG

Registry information

Official study title

Performance of CAST With Different Allergens in Patients With Cat Dander Allergy

Important dates

Study start
2005
Study completion
2006
First posted
Feb 22, 2008
Registry last updated
Nov 20, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.